Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Newronika-DBS-Platfor

More Like This

PR Newswire associated0

Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System

PR Newswire associated0

Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease

PR Newswire associated0

Newronika Appoints Keith Carlton as Executive Chairman to Reinforce Strategic Leadership

WCS: wise cortical strip

WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor

(Credit: INBRAIN Neuroelectronics)

INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

PR Newswire associated0

AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation

Ronovo Surgical Closes Series D Financing